We are live on ! Find out more
LA

Linden Advisors Portfolio holdings

AUM $17.9B
1-Year Est. Return 1.72%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+1.72%
3 Year Est. Return
+2.79%
5 Year Est. Return
+3.4%
10 Year Est. Return
+25.58%
AUM
$16.2B
AUM Growth
+$1.25B
Cap. Flow
-$11.2B
Cap. Flow %
-68.71%
Top 10 Hldgs %
24.75%
Holding
515
New
100
Increased
15
Reduced
8
Closed
43

Sector Composition

Rank Sector Weight
1 Financials 6.22%
2 Healthcare 0.2%
3 Energy 0.19%
4 Industrials 0.11%
5 Consumer Staples 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DMIIR
251
Drugs Made In America Acquisition II Corp Right
DMIIR
$117K ﹤0.01%
+899,899
New +$129K
APXTW
252
Apex Treasury Corp Warrants
APXTW
$7.1M
$117K ﹤0.01%
+425,001
New +$129K
CDROW icon
253
Codere Online Luxembourg Warrants
CDROW
$5.77M
$116K ﹤0.01%
144,407
DYORW
254
Insight Digital Partners II Warrants
DYORW
$2.42M
$115K ﹤0.01%
+324,999
New +$108K
EVAC.WS
255
EQV Ventures Acquisition Corp II Warrants
EVAC.WS
$114K ﹤0.01%
341,664
GTERR
256
Globa Terra Acquisition Corp Rights
GTERR
$114K ﹤0.01%
760,850
POLEW
257
Andretti Acquisition Corp II Warrant
POLEW
$112K ﹤0.01%
400,000
+250,000
+167% +$72.9K
PCAPW
258
ProCap Acquisition Corp Warrant
PCAPW
$111K ﹤0.01%
316,666
SVCCW
259
Stellar V Capital Corp Warrant
SVCCW
$2.18M
$109K ﹤0.01%
350,000
PLMKW
260
Plum Acquisition Corp IV Warrants
PLMKW
$105K ﹤0.01%
350,000
GSHRW
261
Gesher Acquisition Corp II Warrants
GSHRW
$2.66M
$103K ﹤0.01%
249,999
OACCW
262
Oaktree Acquisition Corp III Life Sciences Warrant
OACCW
$99K ﹤0.01%
120,000
HVMCW
263
Highview Merger Corp Warrants
HVMCW
$97.6K ﹤0.01%
+375,001
New +$125K
LEGT.WS
264
DELISTED
Legato Merger Corp III Warrants
LEGT.WS
$94.5K ﹤0.01%
224,999
LATAW
265
Galata Acquisition Corp II Warrant
LATAW
$1.55M
$93.8K ﹤0.01%
+250,000
New +$104K
GPATW
266
GP-Act III Acquisition Corp Warrants
GPATW
$92.4K ﹤0.01%
360,400
DRDBW
267
Roman DBDR Acquisition Corp II Warrants
DRDBW
$2.21M
$91.5K ﹤0.01%
150,000
PACHW
268
Pioneer Acquisition I Corp Warrants
PACHW
$3.04M
$90K ﹤0.01%
375,001
QUMSR
269
Quantumsphere Acquisition Corp Rights
QUMSR
$88K ﹤0.01%
+400,000
New +$104K
ONCHW
270
1RT Acquisition Corp Warrant
ONCHW
$88K ﹤0.01%
127,524
BLZRW
271
Trailblazer Acquisition Corp Warrant
BLZRW
$3.05M
$85.8K ﹤0.01%
+166,665
New +$97.8K
TDACW
272
Translational Development Acquisition Corp Warrants
TDACW
$16.5M
$84.6K ﹤0.01%
299,999
OBAWW
273
Oxley Bridge Acquisition Ltd Warrants
OBAWW
$2.78M
$82.3K ﹤0.01%
350,000
+100,000
+40% +$24.7K
GTERW
274
Globa Terra Acquisition Corp Warrants
GTERW
$81.5K ﹤0.01%
570,637
BCSS.WS
275
Bain Capital GSS Investment Corp Warrants
BCSS.WS
$81.2K ﹤0.01%
+119,998
New +$82.3K

Similar funds

Linden Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Linden Advisors held 515 positions worth $16.2B, up 8.3% from $15B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Linden Advisors withdrew a net $11.2B in Q4 2025, closing 43 positions and reducing 8 holdings. Its most notable exit was Nova, an estimated $29.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 6.2% of assets, up from 5.1% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Linden Advisors opened a new position in Zoetis worth $32.1M.

  • Linden Advisors's largest Q4 2025 buy was Zoetis: 255,200 shares worth $32.1M.
  • Linden Advisors added most to Andretti Acquisition Corp II in Q4 2025, an estimated $7.39M increase.
  • Linden Advisors's biggest Q4 2025 reduction was Core Scientific Inc Tranche 1 Warrants, cutting an estimated $8.88M.
  • Linden Advisors fully exited Nova in Q4 2025, selling an estimated $29.1M.
  • Linden Advisors's ten largest holdings make up 25% of its $16.2B portfolio in Q4 2025.
  • Linden Advisors opened 100 new positions and closed 43 in Q4 2025.
  • Linden Advisors's portfolio value rose 8.3% quarter-over-quarter to $16.2B.

Based on Linden Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.